期刊文献+

川芎嗪联合氟尿嘧啶对胃癌细胞SGC-7901/ADR的杀伤作用 被引量:13

Lethal Effect of Combination of Tetramethylpyrazine and Fluorouracil in Multidrug Resistance of Gastric Carcinoma Cell Lines SGC-7901/ADR
暂未订购
导出
摘要 目的观察川芎嗪(TMP)联合氟尿嘧啶(5-Fu)对胃癌多药耐药细胞SGC7901/ADR细胞的体外杀伤作用。方法采用MTT法观察TMP联合5-Fu对SGC7901/ADR细胞的杀伤作用,光镜下观察并采用流式细胞仪(FCM)测定各药物组细胞周期的分布。结果5-Fu对SGC-7901/ADR细胞的半数抑制率(IC50)为13.001mg/L,与300mg/LTMP联合后,使其的IC50降至1.542mg/L,逆转倍数是8.43倍,与对照组相比差异具有统计学意义(P<0.01)。光镜下可见5-Fu+TMP(终浓度300mg/L)组较5-Fu组癌细胞皱缩变小变圆,出现凋亡改变。FCM分析:TMP联合5-Fu与对照组相比将细胞阻滞在DNA合成前期和静息期-G0/G1期(P<0.05)。结论TMP与5-Fu联合对胃癌多药耐药细胞SGC7901/ADR有较强的杀伤作用,为当前胃癌治疗提供了新思路。 Objective To investigate the lethal effect of combination of TMP and 5-Fu in the multidrug resistance of Gastric Carcinoma Cell Lines SGC-7901/ADR. Methods Gastric carcinoma cell lines SGC- 7901 and the multidrug resistance cell lines SGC-7901/ADR were considered as target cells, MTT assay was used to investigate the lethal effect of combination of TMP and 5-Fu in vitro, which was observed by Light microscope. Flow cytometer(FCM) was employed to investigate the cell cycles. Results The half inhibition ratio(IC50 )of 5-Fu against SGC-7901/ADR was 13. 001 mg/L, which was reduced to 1. 542 mg/L by 300 mg/L TMP, The reversal index was 8. 43 (P〈0. 01 ). Malignant cell volume and morphous which exposed to 5-Fu + TMP became smaller and strinked rounder by Light microscope. FCM revealed that with the effect of 5-Fu + TMP, cell cycle was blocked at presynthetic phase and ambiguous phase-G0/ G1 phase and The cells enter the period of DNA synthesis were reduced, inhibition mitosis of SGC-7901/ ADR(P〈0. 05). Conclusion Combination of 5-Fu and TMP has stronger lethal effect against the multidrugs resistance Cell Lines SGC-7901/ADR in Gastric Carcinoma, which may provid a new therapeusis against Gastric Carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第9期624-626,共3页 Cancer Research on Prevention and Treatment
关键词 胃癌 多药耐药性 SGC7901/ADR细胞 5-Fu 川芎嗪 Gastric Carcinoma MDR SGC-7901/ADR 5-Fu TMP
  • 相关文献

参考文献9

  • 1Chipponi J. Huguier M. Pezel D. et al. Randomized trial of adjuvant chemotherapy after curative for gastric cancer[J]. Am J Surg, 2004,187 (3) : 440-445.
  • 2王玉良 巴彦坤.川芎嗪对心血管组织的药理和电生理作用—一种新的钙离子拮抗剂[J].中西医结合杂志,1985,5(5):291-291.
  • 3Britton RA, Green JA, Warenius HM. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents [J]. Int J Radiat Oncol Biol Phys,1992,24(3):527-531.
  • 4Vassetzky TS, Alghisi GC, Gasser SM, et al. DNA topoisomerase Ⅱ mutation and resistance to anti-tumor drugs[J]. Bioessays, 1995,17(9) : 767-774.
  • 5杨琳,朱兆华.维拉帕米对多药耐药胃癌细胞耐药逆转作用的研究[J].中华消化杂志,2002,22(2):112-113. 被引量:10
  • 6Choi JII, Lim IIY, J oo IIJ, et al. Expression of multidrug resistante-associated protein Ⅰ, P-glyeoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection[J]. Br J Cancer,2002,86(10) : 1578-1585.
  • 7胡艳平,刘健,王庆端,叶启霞,张覃沐.川芎嗪和维拉帕米纠正阿霉素对小鼠艾氏腹水癌的抗药性[J].药学学报,1993,28(1):75-78. 被引量:42
  • 8梁蓉,杨平地,陈协群,白庆咸,黄高升.川芎嗪对白血病HL-60/VCR细胞多药耐药的逆转及其机制研究[J].中华血液学杂志,1999,20(6):323-324. 被引量:50
  • 9杨牡丹,李亮成.胃癌多药耐药基因研究进展[J].山西临床医药,2001,10(3):163-166. 被引量:1

二级参考文献10

共引文献108

同被引文献70

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部